Syndax Pharmaceuticals Q3 EPS $(0.41) Beats $(0.47) Estimate, Sales $379K Beat $370K Estimate

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.47) by 12.77 percent. This is a 39.71 percent increase over losses of $(0.68) per share

Benzinga · 11/07/2019 21:43

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.47) by 12.77 percent. This is a 39.71 percent increase over losses of $(0.68) per share from the same period last year. The company reported quarterly sales of $379 thousand which beat the analyst consensus estimate of $370 thousand by 2.43 percent. This is the same as the same period last year.